Brazil's health regulator (Anvisa) has approved the importation of a vaccine against monkeypox, as more than 4,000 people have been infected, ranking the country third in the world.
As a result of this Anvisa decision, the Ministry of Health can purchase the Imvanex vaccine, produced by the Danish laboratory Bavarian Nordic, through the Pan American Health Organization (PAHO).
In its authorization, Anvisa approved the purchase of . . .